GCN2-IN-1 (A-92) is a potent general control nonderepressible 2 kinase ( GCN2 ) inhibitor with an IC 50 of <0.3 μM in the enzyme assay and an IC 50 of 0.3-3 μM in the cell assay
In Vitro
GCN2-IN-1 (Compound A-92) is a GCN2 inhibitor, which may be useful as a chemotherapeutic drug for the treatment of cancer. MCE has not independently confirmed the accuracy of these methods. They are for reference only.